Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Preisser

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology|December 12, 2018
Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?Elio Mazzone, Sophie Knipper, Francesco A Mistretta, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2019
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomyFelix Preisser, Elio Mazzone, Sophie Knipper, et al.
Frontiers in Surgery|October 26, 2020
Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate CancerTobias Engl, Philipp Mandel, Benedikt Hoeh, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2022
The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?Jens Köllermann, Benedikt Hoeh, Daniel Ruppel, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
European Urology Oncology|May 18, 2019
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results DatabaseMarco Bandini, Elio Mazzone, Felix Preisser, et al.
European Urology Focus|January 26, 2018
Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer PatientsMarco Bandini, Felix Preisser, Sebastiano Nazzani, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
European Urology Focus|January 8, 2018
The Impact of Lymph Node Metastases Burden at Radical ProstatectomyFelix Preisser, Michele Marchioni, Sebastiano Nazzani, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology|December 12, 2018
Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?Elio Mazzone, Sophie Knipper, Francesco A Mistretta, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2019
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomyFelix Preisser, Elio Mazzone, Sophie Knipper, et al.
Frontiers in Surgery|October 26, 2020
Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate CancerTobias Engl, Philipp Mandel, Benedikt Hoeh, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2022
The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?Jens Köllermann, Benedikt Hoeh, Daniel Ruppel, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
European Urology Oncology|May 18, 2019
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results DatabaseMarco Bandini, Elio Mazzone, Felix Preisser, et al.
European Urology Focus|January 26, 2018
Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer PatientsMarco Bandini, Felix Preisser, Sebastiano Nazzani, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
European Urology Focus|January 8, 2018
The Impact of Lymph Node Metastases Burden at Radical ProstatectomyFelix Preisser, Michele Marchioni, Sebastiano Nazzani, et al.
Pageof 17